Powered by 
Google Übersetzer
Google Übersetzer
14 July 2025
CVS Group plc
("CVS" or the "Company")
Block Listing Interim Review
CVS, the UK's listed veterinary group and a leading provider of veterinary services, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements. References to securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").
|
Name of the company: |
CVS Group plc
|
|||
|
Name of relevant scheme: |
1. CVS Group SAYE Plan; and 2. CVS Long Term Incentive Plan
|
|||
|
Period of return: |
From: |
12 January 2025 |
To: |
12 July 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
1. 337,965 2. 68,393 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
1. Nil 2. Nil |
|||
|
Less: Number of securities issued / allotted under scheme(s) during period: |
1. Nil 2. Nil |
|||
|
Equals: Balance under scheme(s) not yet issued / allotted at end of period: |
1. 337,965 2. 68,393 |
|||
|
Number and class of securities originally listed and the date of admission: |
1. 350,000 Ordinary Shares admitted on 30 December 2021 2. 120,000 Ordinary Shares admitted on 15 May 2023 |
|||
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / James Thompson / Milo Bonser
Camarco (Financial PR)
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
